San Juan Capistrano, CA, United States of America

Nazli Azimi

This inventor holds 17 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Peptide Therapeutics. Top assignees: Bioniz, LLC, Bioniz Therapeutics, Inc.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nazli Azimi. Retrieved from https://idiyas.com/inventor/nazli-azimi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 88.2

 

 

Average Co-Inventor Count = 1.7

ph-index = 8

Forward Citations = 114(Granted Patents)


Company Filing History:


Years Active: 2013-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Gamma-C-Cytokine
Peptide Antagonists
Peptide Conjugates
Alopecia Treatment
Cytokine Activity
Modulation Methods
Selective Inhibition
Therapeutic Compositions
17 patents (USPTO):Explore Patents

Title: Innovations by Nazli Azimi: Pioneering Treatments in Alopecia and Related Disorders

Introduction

Nazli Azimi, a prominent inventor based in San Juan Capistrano, California, has made significant contributions to the field of biomedicine with 16 patents to her name. Her innovative work primarily focuses on cytokine signaling and its implications for the treatment of various human diseases, particularly alopecia and associated disorders.

Latest Patents

Among her latest patents, Azimi's research on modulating the effects of gamma-c-cytokine signaling stands out. This includes her inventions that address alopecia and related disorders through the modulation of the γc-family cytokines, specifically Interleukin-2 (IL-2), Interleukin-4 (IL-4), Interleukin-7 (IL-7), Interleukin-9 (IL-9), Interleukin-15 (IL-15), and Interleukin-21 (IL-21). Her patents detail compositions, methods, and kits designed to inhibit, treat, or prevent these disorders. Additionally, she has explored compositions and methods for modulating γc-cytokine activity, which are vital in the treatment of leukemia, autoimmune diseases, and more. Her innovative peptide and peptide derivative antagonists stand out for their ability to inhibit the activity of multiple γc-cytokine family members.

Career Highlights

Nazli Azimi's career includes pivotal roles in companies such as Bioniz, LLC and Bioniz Therapeutics, Inc., where she has developed groundbreaking therapeutic approaches leveraging her extensive knowledge of cytokines. Her work continues to push the boundaries of modern medicine and therapeutics, making significant advances in understanding and treating complex conditions.

Collaborations

Throughout her career, Azimi has collaborated with experts in her field, notably Yutaka Tagaya, who has contributed to her research endeavors. This collaboration has enriched her understanding and output in the realm of cytokine signaling, leading to the development of influential patents.

Conclusion

Nazli Azimi's contributions to the field of biomedical innovation are remarkable. With a strong focus on cytokine modulation and its therapeutic implications, her work continues to hold promise for treating alopecia and other serious health conditions. Her extensive patent portfolio not only reflects her ingenuity but also her dedication to advancing science and medicine for the benefit of patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…